Screening for prostate cancer: a study on the free and total prostate specific antigen.

Journal: Discoveries (Craiova, Romania)
Published Date: Dec 31, 2021

Abstract

BACKGROUND: A variety of biomarkers have been developed to monitor growth of cancerous diseases and to detect them at an early stage. Prostate-specific antigen (PSA) is a valuable prostate cancer biomarker that is now widely used for population screening, diagnosis, and monitoring of patients with prostate cancer. Other factors than prostate cancer can cause elevation of PSA levels therefore, free prostate specific antigen measurements in serum have been proposed in order to improve the specificity of laboratory identification of prostate cancer.

Authors

  • Ridvana Mediu
    Faculty of Applied Science, Medical Science Department, University College LOGOS, Tirana, Albania.
  • Ariol Rama
    Faculty of Applied Science, Medical Science Department, University College LOGOS, Tirana, Albania.
  • Naim Mediu
    General surgeon. Surgery Service, Regional Hospital, Durres, Albania.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals